A rapid immunoassay predicts BRCA1 and BRCA2 mutations in buccal cells

Oncology Reports

Volumn 7, Issue 6, 2000, Pages 1203-1207

  Byrne, T J ^a   Reece, M T ^b   Adams, L A ^b   Huffman, D E ^b   Lane, M A ^b   Cohn, G M ^b  

^a UNIVERSITY OF MASSACHUSETTS   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

BRCA1; BRCA2; Buccal cells; Immunoassay

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; DNA; TRANSCRIPTION FACTOR; TUMOR PROTEIN;

ARTICLE; CHEEK; CHEMISTRY; CLINICAL TRIAL; COMPARATIVE STUDY; CYTOLOGY; DOUBLE BLIND PROCEDURE; FEMALE; GENETIC PREDISPOSITION; GENETIC SCREENING; GENETICS; HUMAN; IMMUNOASSAY; METHODOLOGY; MOUTH MUCOSA; MUTATION; NUCLEOTIDE SEQUENCE; PREDICTION AND FORECASTING; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SINGLE STRAND CONFORMATION POLYMORPHISM; TUMOR SUPPRESSOR GENE;

BRCA1 PROTEIN; BRCA2 PROTEIN; CHEEK; DNA; DNA MUTATIONAL ANALYSIS; DOUBLE-BLIND METHOD; FEMALE; GENES, BRCA1; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HUMANS; IMMUNOASSAY; MOUTH MUCOSA; MUTATION; NEOPLASM PROTEINS; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PREDICTIVE VALUE OF TESTS; RISK FACTORS; SENSITIVITY AND SPECIFICITY; TRANSCRIPTION FACTORS;

EID: 0034321932     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.7.6.1203     Document Type: Article

References (11)

1. Cohn GM, Miller RC, Gould M, Macri CJ and Gimovsky ML: Impact of genetic counseling on primary and preventive care in obstetrics and gynecology. J Reprod Med 44: 7-10, 1999.
2. Adams LA, Byrne TJ, Cohn GM and Reece MT: Method for determining the presence of mutated BRCA protein. United States Patent No. 5, 965, 377, 1999.
3. Byrne TJ, Reece MT, Adams LA, Lane MA and Cohn GM: An antibody assay predictive of BRCA1 mutations in ovarian tumors and normal tissue. Oncol Rep 7: 949-953, 2000.
4. Reece MT, Lane MA, Byrne TJ, Adams LA, Podgaysky AP and Cohn GM: Immunohistochemical analysis of BRCA1 expression in normal human buccal cells. Oncol Rep 5: 1071-1076, 1998.
5. Byrne TJ, Cohn GM, Lane MA, Adams LA, Hoffman DH and Recce MT: Immunohistochemical analysis of BRCA2 expression in normal human buccal cells. Oncol Rep 7: 955-958, 2000.
6. Biesecker BB, Boehnke M, Calzone K, Markel DS, Garber JE, Collins FS and Weber BL: Genetic counseling for families with inherited susceptibility to breast and ovarian cancer. JAMA 269: 1970-1974, 1993.
7. Burke W, Daly M, Garber J, Botkin J, Ellis Kahn MJ, Lynch P, McTiernan A, Offit K, Perlman J, Petersen G, Thomson E, and Varrichhio C: The Cancer Genetics Studies Consortium. Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II BRCA1 and BRCA2. JAMA 277: 997-1003, 1997.
8. Cohn GM: Heritable breast and ovarian cancers. The Female Patient 23: 37-48, 1998.
9. Hoskins KF, Stopfer JE, Calzone KA, Merajver SD, Rebbeck TR, Garber JE and Weber BL: Assessment and counseling for women with a family history of breast cancer. A guide for clinicians. JAMA 273: 577-585, 1995.
10. Epstein N, Cohn G, Cyran F and Fananapazir L: Differences in clinical expression of hypertrophic cardiomyopathy associated with two distinct mutations in the B-myosin heavy chain gene. Circulation 86: 345-352, 1992.
11. Statement of the American Society of Clinical Oncology: Genetic testing for cancer susceptibility. J Clin Oncol 14: 1730-1736, 1996.